Horizon Therapeutics Switzerland Gmbh In Liquidation
Horizon Therapeutics Switzerland Gmbh In Liquidation is a Private limited company (Ltd.) registered in Switzerland under CHE111780762, and its current status with Zefix — Swiss Central Business Names Index is intermediate. The company was incorporated on 15 July 2004 and lists its registered address as Rotkreuz, Switzerland. 2 shareholders are on record for Horizon Therapeutics Switzerland Gmbh In Liquidation, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Zefix — Swiss Central Business Names Index and was last updated on 2 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
2
Two shareholders are currently on record for Horizon Therapeutics Switzerland Gmbh In Liquidation, reflecting the Aktienbuch (share register) maintained under Article 686 of the Swiss Code of Obligations rather than a public filing.
The largest of these is Therapeutics Irland Dac (Co. No. 376554) Horizon, holding 50% — the largest recorded stake — followed by Therapeutics Ireland Designated Activity Company (Co. No. 376554) Horizon at 50%.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Therapeutics Irland Dac (Co. No. 376554) Horizon | 50% | Zefix — Swiss Central Business Names Index | |
| Therapeutics Ireland Designated Activity Company (Co. No. 376554) Horizon | 50% | Zefix — Swiss Central Business Names Index |
Officers
3
Three officers are currently on record for Horizon Therapeutics Switzerland Gmbh In Liquidation, filed with Zefix — Swiss Central Business Names Index. Gilles Moise Marrache serves as Vorsitzender Der Geschäftsführung; Paraskevi Florou serves as Geschäftsführerin; Pius Stefan Baldauf serves as Liquidator.
Management authority at Horizon Therapeutics Switzerland Gmbh In Liquidation sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Horizon Therapeutics Switzerland Gmbh In Liquidation sits 6 levels below its ultimate parent, Amgen Inc., registered in United States. The full chain up to Amgen Inc. is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by Horizon Therapeutics Switzerland Gmbh In Liquidation's own shareholder record.
Amgen Inc.
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Horizon Therapeutics Switzerland Gmbh In Liquidation?
Two shareholders are currently on record for Horizon Therapeutics Switzerland Gmbh In Liquidation, reflecting the Aktienbuch (share register) maintained under Article 686 of the Swiss Code of Obligations rather than a public filing. The largest of these is Therapeutics Irland Dac (Co. No. 376554) Horizon, holding 50% — the largest recorded stake — followed by Therapeutics Ireland Designated Activity Company (Co. No. 376554) Horizon at 50%. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Horizon Therapeutics Switzerland Gmbh In Liquidation's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Horizon Therapeutics Switzerland Gmbh In Liquidation is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Horizon Therapeutics Switzerland Gmbh In Liquidation have on record?
2 shareholders are shown on record for Horizon Therapeutics Switzerland Gmbh In Liquidation.
What is Horizon Therapeutics Switzerland Gmbh In Liquidation's company registration number?
Horizon Therapeutics Switzerland Gmbh In Liquidation's registration number is CHE111780762, filed with Zefix — Swiss Central Business Names Index in Switzerland. Its current status on the register is intermediate.
Is Horizon Therapeutics Switzerland Gmbh In Liquidation still an active company?
Horizon Therapeutics Switzerland Gmbh In Liquidation's status on Zefix — Swiss Central Business Names Index is listed as intermediate, not currently active.
When was Horizon Therapeutics Switzerland Gmbh In Liquidation incorporated?
Horizon Therapeutics Switzerland Gmbh In Liquidation was incorporated on 15 July 2004, according to Zefix — Swiss Central Business Names Index.
What is Horizon Therapeutics Switzerland Gmbh In Liquidation's registered address?
The registered address on file for Horizon Therapeutics Switzerland Gmbh In Liquidation is Rotkreuz, Switzerland.
Who are the officers/directors of Horizon Therapeutics Switzerland Gmbh In Liquidation?
Three officers are currently on record for Horizon Therapeutics Switzerland Gmbh In Liquidation, filed with Zefix — Swiss Central Business Names Index. Gilles Moise Marrache serves as Vorsitzender Der Geschäftsführung; Paraskevi Florou serves as Geschäftsführerin; Pius Stefan Baldauf serves as Liquidator. Management authority at Horizon Therapeutics Switzerland Gmbh In Liquidation sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Horizon Therapeutics Switzerland Gmbh In Liquidation have a parent company or subsidiaries?
Horizon Therapeutics Switzerland Gmbh In Liquidation sits 6 levels below its ultimate parent, Amgen Inc., registered in United States.
Can Zavia monitor changes to Horizon Therapeutics Switzerland Gmbh In Liquidation's ownership over time?
This profile reflects a point-in-time snapshot from Zefix — Swiss Central Business Names Index. Zavia's monitoring API can track changes to Horizon Therapeutics Switzerland Gmbh In Liquidation's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Horizon Therapeutics Switzerland Gmbh In Liquidation's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Switzerland, so records like Horizon Therapeutics Switzerland Gmbh In Liquidation's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Zefix — Swiss Central Business Names Index and was last synced on 2 October 2026.